• Filing Date: 2013-04-12
  • Form Type: 10-K
  • Description: Annual report
v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:    
Net loss from continuing operations $ (1,845,323) $ (12,740,816)
Adjustments to reconcile net loss to net cash provided (used) in Operating activities:    
Depreciation and amortization. 61,172 470,619
Amortization of discounts and deferred costs 354,398 313,082
Impairment of intangible assets, 27,044 3,208,372
Stock issued as payment for services, 114,500 161,600
Warrants issued as payment for services, 29,400 0
Warrants Issued as Compensation, 531,284 0
Warrant Expense, 406,953 2,164,302
Non-cash debt related costs, 180,666 727,522
Stock Issued as payment of expenses, 0 388,080
Re-acquisition of distributorship 907,872 0
(Gain) loss on fair market value of derivative liabilities (4,651,061) 96,490
Increase (decrease) in allowance for uncollectible notes receivable 1,993,233 0
Stock issued for debt related costs 45,748 3,338,200
Gain on Joint Venture 27,137 (27,137)
Loss on debt settlement (97,084) 1,128,914
Prepayment Expense. (56,145) 0
Non-cash expenses 9,210 224,318
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable, net 83,271 382,482
(Increase) decrease in inventory (160,880) 125,981
(Increase) decrease in employee advances 15,308 (27,140)
(Increase) decrease in accrued interest receivable - related parties (28,239) (134,409)
(Increase) decrease in accrued interest receivable (138,299) (143,360)
(Increase) decrease in prepaids and other assets (11,306) 0
Increase (decrease) in allowance for uncollectible interest 170,899 261,179
Increase (decrease) in accrued royalties 375,000 0
Increase (decrease) in accounts payable 200,401 (309,848)
Increase (decrease) in accrued liabilities (26,299) (46,532)
Increase (decrease) in accrued interest payable - related parties 31,918 36,217
Increase (decrease) in accrued interest payable 223,041 58,283
Net cash flows provided (used) in operating activities (1,226,181) (343,601)
Cash flows from investing activities:    
Purchase of notes receivable - related parties 0 (7,318,509)
Proceeds from notes receivable - related parties 371,839 5,982,272
Net cash flows used in investing activities 371,839 (1,336,237)
Cash flows from financing activities:    
Proceeds from notes payable - related parties 511,700 1,331,363
Payments on notes payable - related parties (547,700) (1,617,851)
Proceeds from notes payable 1,599,000 3,240,500
Payments on notes payable (1,129,153) (2,500,500)
Proceeds from debentures 347,500 0
Proceeds from sale of stock 100,000 959,700
Proceeds from exercise of warrants 15,248 0
Proceeds from stock subscriptions receivable 0 219,399
Net cash flows provided by financing activities 896,595 1,632,611
Increase (decrease) in cash 42,253 (47,227)
Cash and cash equivalents, beginning of period 3,608 50,835
Cash and cash equivalents, end of period 45,861 3,608
Cash paid during the period for:    
Interest. 31,661 167,839
Income Taxes. 0 0
Supplemental non-cash investing and financing activities:    
Common stock issued for debt conversion. 348,027 3,218,049
Common stock issued for debentures. 1,332,279 0
Common stock issued for services. 72,000 161,600
Common stock issued for debt related costs. 55,760 3,264,495
Capital contribution from related party on sale of Secure eHealth. 0 326,860
Subscriptions receivable offset with note payable $ 0 $ 72,675